Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Terry_Rosen
|
| gptkbp:collaboratesWith |
gptkb:Gilead_Sciences
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
immuno-oncology
cancer therapeutics |
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
gptkb:Juan_Jaen
gptkb:Terry_Rosen |
| gptkbp:headquartersLocation |
gptkb:Hayward,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Arcus Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableProduct |
domvanalimab
etrumadenant zimberelimab |
| gptkbp:numberOfEmployees |
200-500
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NYSE
|
| gptkbp:stockSymbol |
gptkb:RCUS
|
| gptkbp:website |
https://www.arcusbio.com/
|
| gptkbp:bfsParent |
gptkb:RCUS
|
| gptkbp:bfsLayer |
6
|